Zertia is a pioneering startup in the management of education and risks associated with the use of Artificial Intelligence models in companies, applying an exclusive methodology conceived with leaders in AI research. Simultaneously, Zertia certifications adhere to international ISO standards and IEEE certifications. Zertia ensures regulatory compliance and conformity with international standards in the application of Artificial Intelligence.

- Responsible for launch of the upcoming therapies and label extension, as well as the development, implementation and evaluation of a marketing plan that ensures the achievement of the business objectives for Iberian markets.- Drive all related commercial activities through innovation and fearless.- Manage the x‑functional team and fostering teamwork; ensuring that all activities show our commitment to patients.- Detail in depth analysis of clinical nutrition market, customer needs and the brands situation based on excellent market analysis skills.- Development in implementation the marketing plan that leverages multiple innovative channel to achieve our business goals based on external customer needs.- Monitor meaningful KPIs to evaluate plan progress and success. In several cases I have adjusted the plan and activities based on the results.- Ensure compliance of all activities to the Baxter code of conduct, SOPs and all applicable laws and regulations. - Administer approval of initiatives and materials according to SOPs in ZINC and other compliance systems.- Develop and regularly provide reports to senior management and the x‑functional brand team in cooperation with finance and business analytics functions.- Financial Management: Contribute to accurate budgeting and forecasting as well as being responsible for the management of the promotional budget.- External focus and customer understanding: develop and maintain strong working relationships with key customers and work with an “outside in” perspective. - Ensure that all initiatives add value to our customers.- Communicate effectively within the local and international organization to ensure the motivation and alignment of sales force, and other key people in the achievement of product objectives.- Daily cooperation with medical affairs, sales, market access and government affairs

- Development, adaptation and implementation of the annual Marketing Plan for the products assigned at the Business Unit Hospitals & Biosimilar portfolio.- Responsible for strategical promotion and communication of immunosuppressant drugs, management of key opinionleaders, market research, sales force training and product leadership with internal andexternal customers.- Development of an innovative project for the management of the transplanted patient through the transplant nurse. The VINCVLO program has a WEB of management of patient follow‑up, an e‑learning training that has developed today more than 140 nurses throughout Spain and has received 3 awards for initiative and value‑added service to the patient.

- Development of the Launch Plan of VOLUTSA®, a license of ASTELLAS PHARMA of a drug aimed to treating of patients with BPH associated with LUTS.- Implementation of all the activities involved, created the strategy and positioning of the molecule, packaging, price, design, advertising, external communications, placing into the market (wholesalers, specialists and pharmacies), training plan to the sales team , contact KoL, develop the promotional launching materials, forecast, incentive plan, market research, e‑marketing, medical educationplan and design of local and national events.

Startup business, design and implementation of the Business Plan, selection and management of the workpeople, development of all the marketing and advertising strategies, customer acquisition, suppliers management, pricing, accounting and management of the social networks.

- Product Manager responsible for the indication of head and neck cancer for two years got an increase in market share of 10 points compared to the other indication of drug promotion and 30 points over competitors.- Also I led the indication of colorectal cancer and genomics platform necessary for treatment. Establish 12 centers of reference latest techniques in genetic screening can supply all your test patients beforetreatment decisions.- As head of product I managed different regional treatment guidelines and recommendation, influencing the optimal positioning, managing claims and / or developing strategic plans to reposition maximum success with the drug.

- Development in implementation the Marketing product plan for EPREX® in its Oncology indication with a sales target of 82M. - Develop promotional materials through the cycle´s sale strategic, promotional events andtrainings sales program in collaboration with sales, MAF and Med.- Relationship with KoL.- Experience as a sales rep specialized in Hospitals (Oncology, Hematology and Nephrology)

- Representative of the product EPREX (Epoetin alfa).- Turnover of 1.2 million euros.- Specialised medical visits in the Medical Oncology, Haematology and Nephrology departments. - Pharmaceutical and medical negotiation.

- Representative of the product Durogesic (Fentanyl TTS) with a turnover of 500,000 euros.- Specialised medical visit to hospitals and the area of influence.

Brokerage of government securities and bonds between European countries. United Kingdom, Greece and Portugal zone. Trader of Liffe, Eurex, Meff and products traded on the CBOT and CME.